Company / Current Assets
Cartesian Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$129.3M
FY2025
5-year range
$90.7M / $216.6M
FY2021-FY2025
Trend
-40.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 8 years, ranging from $87M in FY2016 to $217M in FY2024.
Based on SEC 10-K filings.
$129M in FY2025 with a 5-year CAGR of -3.1%.
Improved from $91M to $129M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -4.4%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.1%, indicating a declining trend.
- In FY2025, current assets decreased 40.3% year-over-year.
- Peak current assets was recorded in FY2024.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $129.3M | -40.3% |
| FY2024 | $216.6M | +138.8% |
| FY2023 | $90.7M | -38.8% |
| FY2022 | $148.1M | +2.6% |
| FY2021 | $144.4M | -4.6% |
| FY2020 | $151.3M | +56.6% |
| FY2019 | $96.7M | +11.3% |
| FY2016 | $86.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026